相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
Kirsten G. M. Aspros et al.
NPJ BREAST CANCER (2022)
Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors
Hina Dalal et al.
SCIENTIFIC REPORTS (2022)
Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer
Shunchao Yan et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System
Anne Trinh et al.
MOLECULAR CANCER RESEARCH (2021)
Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies
Yi Wang et al.
PHARMACOLOGICAL RESEARCH (2021)
Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
Yvonne Ziegler et al.
CANCERS (2021)
Advances in epigenetic therapeutics with focus on solid tumors
Ning Jin et al.
CLINICAL EPIGENETICS (2021)
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues
John R. Hawse et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors
Mary J. Laws et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis
Hawra Karim et al.
SCIENTIFIC REPORTS (2019)
Update on ERbeta
Jan-Ake Gustafsson et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Yvonne Ziegler et al.
NPJ BREAST CANCER (2019)
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Alice Lee et al.
CANCER TREATMENT REVIEWS (2018)
Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality
Giulia Pinton et al.
ONCOGENESIS (2018)
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis
Jordan M. Reese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data
Steven Xijin Ge et al.
BMC BIOINFORMATICS (2018)
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity
Adam W. Nelson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and Tumors
Yuechao Zhao et al.
CANCER RESEARCH (2017)
SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells
Giulia Pinton et al.
ONCOTARGET (2016)
Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
Zhiyuan Tang et al.
ONCOTARGET (2016)
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface
Erik R. Nelson et al.
ONCOTARGET (2016)
Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ
Ameet K. Mishra et al.
ONCOTARGET (2016)
Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis
Yuechao Zhao et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
Jordan M. Reese et al.
BMC CANCER (2014)
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
Anna Bergamaschi et al.
BREAST CANCER RESEARCH (2014)
Research Resource: Global Identification of Estrogen Receptor β Target Genes in Triple Negative Breast Cancer Cells
Erin K. Shanle et al.
MOLECULAR ENDOCRINOLOGY (2013)
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
Zeynep Madak-Erdogan et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells
Gui Xian Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CCN5, a Novel Transcriptional Repressor of the Transforming Growth Factor β Signaling Pathway
Michele Sabbah et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Jonathan D. Marotti et al.
MODERN PATHOLOGY (2010)
Genome-Wide Dynamics of Chromatin Binding of Estrogen Receptors alpha and beta : Mutual Restriction and Competitive Site Selection
Tze Howe Charn et al.
MOLECULAR ENDOCRINOLOGY (2010)
CCN5: biology and pathophysiology
Joshua W. Russo et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2010)
Estrogen receptors α and β as determinants of gene expression:: Influence of ligand, dose, and chromatin binding
Edmund C. Chang et al.
MOLECULAR ENDOCRINOLOGY (2008)
Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells
Edmund C. Chang et al.
ENDOCRINOLOGY (2006)
Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
G. P. Skliris et al.
BRITISH JOURNAL OF CANCER (2006)
GREB1 is a critical regulator of hormone dependent breast cancer growth
JM Rae et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Indazole estrogens:: Highly selective ligands for the estrogen receptor β
M De Angelis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype
J Frasor et al.
ENDOCRINOLOGY (2003)
Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region
I Choi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Estrogen receptor transcription and transactivation Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer
BS Katzenellenbogen et al.
BREAST CANCER RESEARCH (2000)
分享论文
